Broad Substrate Specificity ATP-Binding Cassette Transporter ABCG2 (ABCG2) Antibody

312€ (60 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Broad Substrate Specificity ATP-Binding Cassette Transporter ABCG2 (ABCG2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx006789
tested applications
WB, IF/ICC
Description
ABCG2 Antibody is a Rabbit Polyclonal Antibody against ABCG2.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Broad Substrate Specificity ATP-Binding Cassette Transporter ABCG2 (ABCG2) |
Host | Rabbit |
Reactivity | Human, Mouse, Rat |
Recommended Dilution | WB: 1/500 - 1/2000, IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Purification | Purified by affinity chromatography. |
Size 1 | 60 µl |
Size 2 | 120 µl |
Size 3 | 200 µl |
Form | Liquid |
Tested Applications | WB, IF/ICC |
Buffer | PBS, pH 7.3, containing 0.05% Proclin-300, 50% glycerol. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | Q9UNQ0 |
Gene ID | 9429 |
NCBI Accession | NP_004818.2 |
Alias | ABC15,ABCP BCRP,BCRP1 BMDP,CD338,CDw338 |
Background | Antibody anti-ABCG2 |
Status | RUO |
Note | Concentration: 1 mg/ml - |
Descripción
ABCG2, also known as the breast cancer resistance protein (BCRP), is a well-characterized ATP-binding cassette transporter involved in drug efflux and xenobiotic clearance. It is highly expressed in barrier tissues such as the intestine, liver, kidneys, and blood-brain barrier, where it protects cells by exporting a wide range of substrates, including drugs, toxins, and endogenous metabolites. ABCG2 plays a pivotal role in pharmacokinetics, influencing drug absorption, distribution, and elimination. It is also critical in stem cell biology, where it acts as a marker for side population cells due to its role in drug resistance and dye efflux. Overexpression of ABCG2 is a major contributor to multidrug resistance in cancer, as it actively pumps chemotherapeutic agents out of tumor cells, reducing their efficacy. Structurally, ABCG2 is a half-transporter that forms functional homodimers to mediate ATP-driven substrate transport. Dysregulation of ABCG2 has been linked to diseases such as gout and certain cancers, making it a target of interest in oncology and pharmacology.
Related Products

Human ABCG2(ATP-binding cassette sub-family G member 2) ELISA Kit
Ver Producto
Rat ABCG2(ATP-binding cassette sub-family G member 2) ELISA Kit
Ver Producto